These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31695430)

  • 1. LncRNA CASC15 Functions As An Unfavorable Predictor Of Ovarian Cancer Prognosis And Inhibits Tumor Progression Through Regulation Of miR-221/ARID1A Axis.
    Shi Y; Gao S; Zheng Y; Yao M; Ruan F
    Onco Targets Ther; 2019; 12():8725-8736. PubMed ID: 31695430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis.
    Zhang H; Wang J; Ren T; Huang Y; Yu Y; Chen C; Huang Q; Guo W
    Onco Targets Ther; 2020; 13():12055-12066. PubMed ID: 33262606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis.
    Sun J; Xiong Y; Jiang K; Xin B; Jiang T; Wei R; Zou Y; Tan H; Jiang T; Yang A; Jia L; Wang L
    J Exp Clin Cancer Res; 2021 Jan; 40(1):12. PubMed ID: 33407675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulated expression of lncRNA TUBA4B predicts unfavorable prognosis and suppresses glioma progression by sponging miR-183 to regulate SMAD4 expression.
    Bao XN; Wang SW; Li Y
    Arch Med Sci; 2024; 20(3):863-875. PubMed ID: 39050167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer.
    Bai Y; Zhang G; Cheng R; Yang R; Chu H
    Cell Cycle; 2019 Sep; 18(18):2323-2331. PubMed ID: 31378128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
    Shan S; Li HF; Yang XY; Guo S; Guo Y; Chu L; Xu MJ; Xin DM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):507-512. PubMed ID: 30720157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CACS15 regulates tongue squamous cell carcinoma cell behaviors and predicts survival.
    Wu X; Ma J; Chen J; Huang H
    BMC Oral Health; 2019 Oct; 19(1):231. PubMed ID: 31665008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p.
    Zhang YN; Liu B; Jiang T; Li Q
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):611-618. PubMed ID: 32016962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9814-9820. PubMed ID: 31799648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS5 inhibits the proliferation and invasion of ovarian clear cell carcinoma via the miR-31-5p/ARID1A axis.
    Zhang J; Yang ZM; Huang Y; Wang KN; Xie Y; Yang N
    Kaohsiung J Med Sci; 2021 Nov; 37(11):940-950. PubMed ID: 34414664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
    Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
    Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
    Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8303-8309. PubMed ID: 31646560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer.
    Yao XM; Tang JH; Zhu H; Jing Y
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5661-5667. PubMed ID: 29272000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CASC15 predicts unfavorable prognosis and exerts oncogenic functions in non-small cell lung cancer.
    Li M; Chen Y; Zhu J; Gao Z; Wang T; Zhou P
    Am J Transl Res; 2019; 11(7):4303-4314. PubMed ID: 31396336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA
    Wang C; Zi H; Wang Y; Li B; Ge Z; Ren X
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):763-769. PubMed ID: 32285705
    [No Abstract]   [Full Text] [Related]  

  • 16. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis.
    Lei X; Li L; Duan X
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30429229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through down-regulating SP-A by sponging to miR-424.
    Li H; Hao J; Yu W
    Open Med (Wars); 2023; 18(1):20230710. PubMed ID: 37465354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
    Zhu LM; Li N
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8897-8904. PubMed ID: 31696476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC15 Promotes Cerebral Ischemia/Reperfusion Injury via miR-338-3p/ETS1 Axis in Acute Ischemic Stroke.
    Chen C; Wang L; Wang L; Liu Q; Wang C
    Int J Gen Med; 2021; 14():6305-6313. PubMed ID: 34629895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.